HEPRADEL, created in 2007 (United States), from 18 sister brands and 2214 competing brands. The HEPRADEL brand is owned by Vertex Pharma, a company listed in New York. HEPRADEL belongs to the Biotechnology business sector.

HEPRADEL is a brand of Vertex Pharma (VRTX) Share price

International deposit : 2007 Business sector Biotechnology

Share price and profitability of the share Vertex Pharma (HEPRADEL)

Buy Vertex Pharma share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 397.70

Portfolio valuation
Vertex Pharma (HEPRADEL) over 5 years* USD 920.97

Stock market history Vertex Pharma (HEPRADEL)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Vertex Pharma

VERTEX
VERTEX
See more brands of Vertex Pharma

Rival brands
HEPRADEL

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS